Fatal infection caused by Francisella tularensis in a neutropenic bone marrow transplant recipient

被引:19
作者
Sarria, JC
Vidal, AM
Kimbrough, RC
Figueroa, JE
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Div Infect Dis, Dept Internal Med, Lubbock, TX 79430 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Div Infect Dis, Dept Internal Med, New Orleans, LA 70112 USA
关键词
bone marrow transplantation; Francisella tularensis; immunocompromise; neutropenia;
D O I
10.1007/s00277-002-0570-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Francisella tularensis is one of the most infectious pathogenic bacteria known. Even though immunity against this organism is thought to be primarily T cell mediated, some evidence suggests that neutrophils may also play an important protective role. We report a case of tularemia in a neutropenic bone marrow transplant recipient that sheds light on the importance of neutrophils in protection against this infection and review clinical aspects of this fascinating infection emphasizing areas of interest for immunocompromised hosts.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 20 条
[1]  
*AM PUBL ASS, 2000, CONTR COMM DIS MAN, P532
[2]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P182
[3]  
Culkin SJ, 1997, J IMMUNOL, V158, P3277
[4]   Tularemia as a biological weapon - Medical and public health management [J].
Dennis, DT ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Friedlander, AM ;
Hauer, J ;
Layton, M ;
Lillibridge, SR ;
McDade, JE ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2763-2773
[5]   STREPTOMYCIN AND ALTERNATIVE AGENTS FOR THE TREATMENT OF TULAREMIA - REVIEW OF THE LITERATURE [J].
ENDERLIN, G ;
MORALES, L ;
JACOBS, RF ;
CROSS, JT .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (01) :42-47
[6]   TULAREMIA - A 30-YEAR EXPERIENCE WITH 88 CASES [J].
EVANS, ME ;
GREGORY, DW ;
SCHAFFNER, W ;
MCGEE, ZA .
MEDICINE, 1985, 64 (04) :251-269
[7]   Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR [J].
Grunow, R ;
Splettstoesser, W ;
McDonald, S ;
Otterbein, C ;
O'Brien, T ;
Morgan, C ;
Aldrich, J ;
Hofer, E ;
Finke, EJ ;
Meyer, H .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (01) :86-90
[8]   Ciprofloxacin for treatment of tularemia in children [J].
Johansson, A ;
Berglund, L ;
Gothefors, L ;
Sjöstedt, A ;
Tärnvik, A .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (05) :449-453
[9]  
Johansson A, 2000, J CLIN MICROBIOL, V38, P22
[10]   THE PRODUCTION OF OXYGEN METABOLITES AND THEIR POSSIBLE REGULATORY ROLE IN THE COURSE OF TULAREMIA INFECTION [J].
KOVAROVA, H ;
MACELA, A ;
STULIK, J .
FOLIA MICROBIOLOGICA, 1990, 35 (05) :413-422